Stanley D Glick

Title: The Innovative Contributions of Stanley D. Glick

Introduction

Stanley D. Glick is a notable inventor based in Williamstown, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of animal models for studying neurological disorders. His work has implications for understanding diseases that involve dopaminergic dysfunction.

Latest Patents

Glick holds a patent for a transgenic mouse model designed to study diseases involving dopaminergic dysfunction. The patent, titled "Transgenic mouse as model for diseases involving dopaminergic dysfunction," describes a transgenic mouse exhibiting a circling phenotype due to insertional mutagenesis. This innovative model was created by introducing genetic material into the mouse genome at an embryonic stage, which alters an endogenous genetic locus affecting motor function. The transgenic mouse line, designated TgX15, has been identified as a valuable resource for investigating the molecular genetic mechanisms that influence brain function and behavior. Furthermore, these mice may aid in evaluating new therapeutic agents for disorders such as Parkinsonism and schizophrenia. Glick's patent portfolio includes 1 patent.

Career Highlights

Stanley D. Glick is associated with Health Research, Inc., where he continues to contribute to advancements in health and biomedical research. His work has garnered attention for its potential to improve understanding and treatment of neurological conditions.

Collaborations

Glick has collaborated with notable colleagues, including John J. Mullins and Anil K. Ratty, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Stanley D. Glick's innovative work in developing a transgenic mouse model represents a significant advancement in the study of dopaminergic dysfunction. His contributions are poised to facilitate further research and therapeutic developments in the field of neurology.